World Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Sell
28,563
-1,558
-5% -$205K 0.07% 304
2026
Q1
$4.2M Sell
30,121
-1,632
-5% -$229K 0.07% 301
2025
Q4
$3.9M Buy
31,753
+3,589
+13% +$436K 0.06% 310
2025
Q3
$3.13M Buy
28,164
+1,053
+4% +$120K 0.06% 313
2025
Q2
$3.01M Buy
27,111
+750
+3% +$79.8K 0.07% 300
2025
Q1
$2.95M Buy
26,361
+1,874
+8% +$193K 0.08% 288
2024
Q4
$2.26M Sell
24,487
-1,512
-6% -$136K 0.06% 308
2024
Q3
$2.18M Buy
25,999
+6,535
+34% +$499K 0.07% 284
2024
Q2
$1.34M Buy
+19,464
New +$1.3M 0.08% 220

Other funds holding GILD

World Investment Advisors's GILD Position: Q2 2026 in Review

World Investment Advisors reduced its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, selling an estimated $205K and leaving 28,563 shares worth $3.97M. The position accounts for 0.07% of the portfolio, ranked #304.

World Investment Advisors first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.2M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • World Investment Advisors held 28,563 shares of Gilead Sciences worth $3.97M as of Q2 2026.
  • World Investment Advisors sold 1,558 Gilead Sciences shares in Q2 2026, an estimated $205K.
  • Gilead Sciences made up 0.07% of World Investment Advisors's portfolio in Q2 2026, its #304 holding.
  • World Investment Advisors first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
  • World Investment Advisors's Gilead Sciences position peaked at $4.2M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.